| [1] |
Liu KJ, Liu JW, Li XR, et al. Epidemiology study of risk factors on Uigur and Han cervical cancer in Xinjiang[J]. Xinjiang Yi Ke Da Xue Xue Bao, 2008, 31(10):1335-8. [刘开江, 刘继文, 李晓荣, 等. 新疆维, 汉妇女宫颈癌发病危险因素的流行病学研究[J]. 新 疆医科大学学报, 2008, 31(10):1335-8.]
|
| [2] |
Lalai•Suzuke,Peng YH,Zhou K,et al.The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang[J].Xinjiang Yi Ke Da Xue Xue Bao,2006,29 (7):569-71. [拉莱•苏祖克, 彭玉华, 周康, 等. 新疆不同民族宫颈癌发病趋 势分析[J]. 新疆医科大学学报, 2006, 29(7):569-71.]
|
| [3] |
Zhang GQ, LIU KJ, Lai XJ, et al. Distribution of malignant tumor patients in hospital from 1989 to 2002 in the Affiliated Tumor Hospital of Xinjiang Medical University[J]. Xinjiang Yi Ke Da Xue Xue Bao, 2003, 26(4):393-4. [张国庆,刘开江,赖小军,等.新 医大附属肿瘤医院1989~2002年住院病人恶性肿瘤分布[J].新 疆医科大学学报, 2003, 26(4):393-4.]
|
| [4] |
Hao Z,Liu HM,Haimiti•Abudulimu.Expression of HSP90 and HPV16 in cervical cancer in Urghur women[J].Zhong Liu Fang Zhi Yan Jiu,2010,37(1):74-6,80.[郝治,刘红梅,海米提•阿布都力 木.维吾尔族妇女宫颈癌组织中HSP90的表达及其与HPV16的 相关性[J].肿瘤防治研究,2010,37(1):74-6,80.]
|
| [5] |
Sölétormos G,Duffy MJ,Hayes DF, et al.Design of tumor biomarker-monitoring trials:a proposal by the European Group on tumor markers[J].Clin Chem,2013,59(1):52-9.
|
| [6] |
Zhang L,Tang HQ.Changes and clinical signifi cance of coagulation markers in patients with gastric cancer[J]. Jian Yan Yi Xue Yu Lin Chuang,2012, 9(2):166-7,169. [张琳, 唐沪强. 胃癌患者凝血指 标变化及临床意义[J]. 检验医学与临床, 2012,9(2):166-7,169. ]
|
| [7] |
Rickles FR.Mechanisms of cancer-induced thrombosis in cancer[J]. Pathophysiol Haemost Thromb,2006, 35(1-2):103-10.
|
| [8] |
Chen N, Xu K. Application and prospect of Heparin antithrombin in cancer therapy[J]. Chongqing Yi Xue,2011,40(20):2062-4.[陈 楠, 徐昆. 肝素抗凝血酶III在肿瘤治疗中的应用与展望[J]. 重庆 医学, 2011,40(20):2062-4.]
|
| [9] |
Lee S,Hong SW,Min BH,et al.Essential role of clusterin in pancreas regeneration[J].Dev Dyn,2011,240(3):605-15.
|
| [10] |
Ekici S,Ero?lu A,Do?an Ekici AI,et al.Clusterin immunoreactivity as a predictive factor for progression of non-muscle-invasive bladder carcinoma[J]. Urol Int,2011,86(1):31-5.
|
| [11] |
Zhang JJ,Yu YL,Du Y.The research progression of clusterin in tumor[J].Neimenggu Yi Xue Za Zhi,2011,43(4):445-8.[张建举, 于跃利,杜颖.Clusterin在肿瘤中的研究进展[J].内蒙古医学杂 志,2011,43(4):445-8.]
|
| [12] |
Nakamura E,Iwakawa M,Furuta R,et al. Villin1, a novel diagnostic marker for cervical adenocarcinoma[J].Cancer Biol Ther,2009, 8( 12):1146-53.
|
| [13] |
Zavros Y,Eaton KA,Kang W,et al.Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma[J].Oncogene,2005,24(14):2354-66.
|
| [14] |
Kennedy MT,Jordan RC,Berean KW,et al.Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma[J]. J Clin Pathol,2004,57(9):932-7.
|
下载:
